[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340566-105":59,"doc-detail-340566-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","pyrvinium-pamoate-alone-and-with-gemcitabine-exhibits-anti-pancreatic-cancer-activity-in-2d-and-3d-cell-culture-models","Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models","","Pancreatic cancer remains difficult to treat, with current regimens failing to meaningfully extend patient survival. This work evaluates drug repurposing using pyrvinium pamoate as an anti-pancreatic candidate, alone and combined with the first-line agent gemcitabine. Using 2D cultures and 3D spheroids, pyrvinium pamoate shows short- and long-term cytotoxicity, suppresses EMT, invasion, and migration, and promotes DNA damage. It additionally inhibits stemness markers and the PI3K/AKT pathway, triggers S-phase arrest, and induces apoptotic and autophagic cell death. Synergy with gemcitabine supports its therapeutic potential.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pyrvinium-pamoate-alone-and-with-gemcitabine-exhibits-anti-pancreatic-cancer-activity-in-2d-and-3d-cell-culture-models/340566/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pyrvinium-pamoate-alone-and-with-gemcitabine-exhibits-anti-pancreatic-cancer-activity-in-2d-and-3d-cell-culture-models/340566.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address in pancreatic cancer treatment?","Question",{"text":113,"@type":114},"Pancreatic cancer has a poor prognosis, and existing treatment lines do not significantly improve survival. The study focuses on finding more effective strategies urgently needed for better outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What models and experimental systems were used to test pyrvinium pamoate?",{"text":118,"@type":114},"The study used pancreatic cancer 2D cell cultures and 3D spheroids to evaluate cytotoxicity and functional effects on cancer cell behaviors.",{"name":120,"@type":111,"acceptedAnswer":121},"How does pyrvinium pamoate affect cancer cells mechanistically?",{"text":122,"@type":114},"It induces DNA damage, inhibits stemness markers, blocks the PI3K/AKT survival pathway, triggers S-phase cell cycle arrest, and causes apoptotic and autophagic cell death.",{"name":124,"@type":111,"acceptedAnswer":125},"Does pyrvinium pamoate work better alone or with gemcitabine?",{"text":126,"@type":114},"The findings show pyrvinium pamoate is effective as a single agent and acts synergistically with gemcitabine in both 2D and 3D pancreatic cancer cell culture models.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},340566,1790138523,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Journal of Cellular and Molecular Medicine  \nORIGINAL ARTICLE  OPEN ACCESS   \nPyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models  \nKarabo Serala | Jinming Bai  | Sharon Prince   \nDepartment of Human Biology, University of Cape Town, Observatory, Cape Town, South Africa Correspondence: Sharon Prince ([sharon.prince@uct.ac.za](sharon.prince@uct.ac.za))  \nReceived: 19 June 2024 | Revised: 11 October 2024 | Accepted: 7 November 2024  \nFunding: The University of Cape Town (UCT Vision 2030 Grand Challenges Programme), the National Research Foundation of South Africa (Competitive Programme for Rated Researchers), the International Centre for Genetic Engineering and Biotechnology (Collaborative Research Programme), the South African Medical Research Council (Self-Initiated Research Grant and Gynaecological Cancer Research Centre) . The views and opinions expressed are those of the author(s) and do not necessarily represent the official views of the SAMRC.  \nKeywords: drug combinations | drug repurposing | gemcitabine | pancreatic cancer | pyrvinium pamoate  \nABSTRACT  \nPancreatic cancer is an intractable disease with the worst prognosis of all common cancers. The treatment regimens currently used for pancreatic cancer do not significantly impact patient survival, and therefore, effective treatment strategies are urgently needed. Drug repurposing, which identifies new indications for existing and approved drugs, has proven to be a desirable approach to anti-cancer drug discovery. Indeed, the antihelminthic drug, pyrvinium pamoate, has shown promise as an anti-pancreatic cancer drug. However, the only mechanism of action ascribed to this has been its ability to inhibit mitochondrial function. This study showed, using pancreatic cancer 2D cell cultures and 3D spheroids, that pyrvinium pamoate exhibited short-and longterm cytotoxicity, inhibited epithelial-to-mesenchymal transition and cell invasion and migration. Mechanistically, pyrviniumpamoate induced DNA damage, inhibited stemness markers and the PI3K/AKT cell survival pathway, triggered an S-phase cell cycle arrest and induced apoptotic and autophagic cell death. Importantly, pyrvinium pamoate acted synergistically with the first-line drug, gemcitabine, in 2D and 3D pancreatic cancer cell culture models. This study provides evidence that pyrviniumpamoate is effective as a single agent and in combination with gemcitabine for the treatment of pancreatic cancer.  \n1 | Introduction  \nPancreatic cancer (PC) has the worst prognosis of all common cancers, and its worldwide incidence is continuously increasing [1] . The two major PC subtypes are pancreatic ductaladenocarcinoma (PDAC) and pancreatic neuroendocrine tumours (PNETs), with PDAC being the more aggressive subtype and accounting for 90% of all PC cases [2, 3] . At present, surgery is the only curative option for PDAC; however, only 15%–20% of patients present with resectable disease, and of these, a large proportion are not eligible for surgical resection due to immense vascular involvement [4] . The remaining 80%  \nof patients present with either locally advanced or metastatic disease [1] . Clinical care for these patients is through systemic chemotherapy, with the first lines of therapy being gemcitabine (GEM), GEM plus nab-paclitaxel or FOLFIRINOX [5] . However, these treatment modalities do not significantly impact patient survival due to tumour drug resistance and recurrence, as well as their high toxicity profiles. Developing new drugs to overcome these limitations is challenging, asthe drug development pipeline is time-consuming, risky and expensive [6] . Drug repurposing has therefore gained traction as an alternative approach to anti-cancer drug discovery [7] . The rationale for this is that the candidate drugs have  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction","cbCaikHLhtgbbijF","https://ap.wps.com/l/cbCaikHLhtgbbijF","pdf",10552914,14,"English","# Introduction\n## Background on pancreatic cancer and current therapies\n## Rationale for drug repurposing\n# Pyrvinium pamoate in prior research\n## Reported targets and mechanisms\n## Relevance to pancreatic cancer and the tumor microenvironment","[{\"question\":\"What problem does the study address in pancreatic cancer treatment?\",\"answer\":\"Pancreatic cancer has a poor prognosis, and existing treatment lines do not significantly improve survival. The study focuses on finding more effective strategies urgently needed for better outcomes.\"},{\"question\":\"What models and experimental systems were used to test pyrvinium pamoate?\",\"answer\":\"The study used pancreatic cancer 2D cell cultures and 3D spheroids to evaluate cytotoxicity and functional effects on cancer cell behaviors.\"},{\"question\":\"How does pyrvinium pamoate affect cancer cells mechanistically?\",\"answer\":\"It induces DNA damage, inhibits stemness markers, blocks the PI3K/AKT survival pathway, triggers S-phase cell cycle arrest, and causes apoptotic and autophagic cell death.\"},{\"question\":\"Does pyrvinium pamoate work better alone or with gemcitabine?\",\"answer\":\"The findings show pyrvinium pamoate is effective as a single agent and acts synergistically with gemcitabine in both 2D and 3D pancreatic cancer cell culture models.\"}]","Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models | PDF",1790037381,35,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33dec34ed1cdc57862a2940d7ad9049b.webp",983,1291,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8382593546814f1d9d9374eb44b46a7b.webp",982,1290,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f63ab402d54057c813ddf06eb2a11f5.webp",981,1289,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4424b4ed7375f9867653571d44fab81f.webp",980,1287]